BMR Solutions

Company Overview

Snapshot

Founded in March 2011 by Ronen Kahana and Inessa (Inna) Solomonik, BMR Solutions operates with 1–10 employees. The company holds a patent and is currently in the Pre-Funding stage. BMR Solutions ceased to operate in November 2020.

Business overview

BMR Solutions is a biopharmaceutical company focused on the discovery and development of novel compounds to activate and enhance stem cells. The company's core technology aims to increase the supply of bone marrow stem cells from a patient's own body to treat hematological disorders resulting from cancer treatments, radiation exposure, and other medical conditions. BMR Solutions primarily serves the pharmaceutical and healthcare sectors, with a focus on patients undergoing chemotherapy and/or radiation treatments, developing supportive care for those with impaired bone marrow production and abnormal blood counts.

Company Intelligence Q&A

What is BMR Solutions' primary focus?

BMR Solutions is a biopharmaceutical company focused on discovering and developing novel compounds for the activation and enhancement of stem cells to treat hematological disorders.

When was BMR Solutions founded and by whom?

BMR Solutions was founded in March 2011 by Ronen Kahana and Inessa (Inna) Solomonik.

What is the status of BMR Solutions?

BMR Solutions is currently non-active, having ceased operations in November 2020.

What is BMR Solutions' most advanced drug candidate?

BMR Solutions develops its most advanced drug candidate, BMRH-1001, as a supportive care for cancer patients with impaired bone marrow production and abnormal blood counts, such as those undergoing chemotherapy and/or radiation treatments.

In which markets does BMR Solutions operate?

BMR Solutions operates in the Israel geomarket, with an office in Natick, MA, USA.